Case Law Details
Case Name : ARI Healthcare Private Ltd. Vs ACIT (ITAT Mumbai)
Related Assessment Year : 2022-23
Courts :
All ITAT ITAT Mumbai
Become a Premium member to Download.
If you are already a Premium member, Login here to access.
Sponsored
ARI Healthcare Private Ltd. Vs ACIT (ITAT Mumbai)
ITAT Mumbai held that market development expenses towards sale of product is revenue in nature hence denial of same is unsustainable. Accordingly, market development expenses being revenue expenditure is allowed as deduction.
Facts- The assessee is engaged in the business of manufacturer and sale of pharmaceuticals, medicinal chemicals and botanical products. In course of assessment proceedings, AO noticed that the assessee has debited an amount of Rs.2,16,04,410/-towards sales and marketing expenses. Whereas
Please become a Premium member. If you are already a Premium member, login here to access the full content.
Sponsored
Kindly Refer to
Privacy Policy &
Complete Terms of Use and Disclaimer.